Considering Plant Metabolites and Their Synthetic Derivatives as Candidates for the Development of Drugs Directed Against Multidrug Resistant (MDR) Tumors.

  • 3,524

    Total downloads

  • 13k

    Total views and downloads

About this Research Topic

Submission closed

Background

Even though pharmacological agents currently used in oncology play a decisive role in the treatment of cancer, the development of multidrug resistance (MDR) and the consequent failures in chemotherapy highlights the dire need to discover new effective agents. One of the main mechanism encountered in MDR, is the overexpression of efflux pumps, in particular of the transporters belonging to the ATP binding cassette (ABC) family.

Notably, plants have been an endless and vital source of compounds with great structural diversity showing various possible modes of action against MDR cancer cells. The enormous potential that lies in plants provide us with new and active chemical entities that can be used by themselves or as scaffolds for the synthesis of derivatives. These facts, serve as a powerful motivation that moves scientists across the globe to continue searching for their therapeutic potential. These structures will enrich natural product libraries to be used for the discovery of lead compounds and the development of drug candidates for a successful chemotherapy against different resistant phenotypes.

This Research Topic intends to display and discuss cutting-edge research illustrating the potential of plant-derived entities and their synthetic derivatives against MDR tumors. We want to bring together and encourage organic chemists, pharmacognocists, pharmacologists, toxicologists, biologists, artificial intelligence experts, computer-aided drug design scientists and clinicians to join forces and collaborate as a multidisciplinary team to tackle this clinical problem. We encourage authors to place a focus on the anti-cancer activity of such plant-derived metabolites and their synthetic agents, their underlying mechanism of action and also on the rational design and synthesis of relevant derivatives to be considered. Ultimately, this can pave the way to improve the outcome and achieve cures in as many patients with cancer as possible.

This article collection will provide extensive and applied knowledge and aim to stimulate interest to find new avenues to develop potential therapeutic agents against multidrug resistance (MDR) tumors.

This Topic will welcome submissions of Original Research, Systematic Reviews, Reviews, Mini Reviews, Perspectives or Opinion dealing with, but not limited to the following themes:

● Identification of compounds obtained from plants and/or their synthetic analogues with proven inhibitory activity against MDR tumor cells.

● In vivo models developed to test plant-derived compounds and synthetic analogues for their inhibitory activity against MDR tumor cells.

● Underlying mechanisms of action behind plant-derived compounds and their synthetic analogues as they act against cancer cells with observed MDR phenotypes.

● Computer-Aided Drug Design (CADD) as virtual tool to be used for screening and prediction of bioactive compounds against MDR tumor cells.

● Structure activity relationship studies (SARS) dealing with synthetic derivatives of natural products that are shown to be active against MDR phenotypes.

Important note: All manuscripts submitted to this collection will need to follow the Guidelines for the conception/peer-review of submissions of the Experimental Pharmacology and Drug Discovery Section. Studies carried out with crude extracts/multiherbal preparations or Original Research based solely on in silico techniques will not be considered for review.

Keywords: Plant-derived compounds, synthetic derivatives, multidrug resistant (MDR) tumors, ABC transporters, cancer therapy, phytochemicals

Important note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.

Frequently asked questions

  • Frontiers' Research Topics are collaborative hubs built around an emerging theme.Defined, managed, and led by renowned researchers, they bring communities together around a shared area of interest to stimulate collaboration and innovation.

    Unlike section journals, which serve established specialty communities, Research Topics are pioneer hubs, responding to the evolving scientific landscape and catering to new communities.

  • The goal of Frontiers' publishing program is to empower research communities to actively steer the course of scientific publishing. Our program was implemented as a three-part unit with fixed field journals, flexible specialty sections, and dynamically emerging Research Topics, connecting communities of different sizes and maturity.

    Research Topics originate from the scientific community. Many of our Research Topics are suggested by existing editorial board members who have identified critical challenges or areas of interest in their field.

  • As an editor, Research Topics will help you build your journal, as well as your community, around emerging, cutting-edge research. As research trailblazers, Research Topics attract high-quality submissions from leading experts all over the world.

    A thriving Research Topic can potentially evolve into a new specialty section if there is sustained interest and a growing community around it.

  • Each Research Topic must be approved by the specialty chief editor, and it falls under the editorial oversight of our editorial boards, supported by our in-house research integrity team. The same standards and rigorous peer review processes apply to articles published as part of a Research Topic as for any other article we publish.

    In 2023, 80% of the Research Topics we published were edited or co-edited by our editorial board members, who are already familiar with their journal's scope, ethos, and publishing model. All other topics are guest edited by leaders in their field, each vetted and formally approved by the specialty chief editor.

  • Publishing your article within a Research Topic with other related articles increases its discoverability and visibility, which can lead to more views, downloads, and citations. Research Topics grow dynamically as more published articles are added, causing frequent revisiting, and further visibility.

    As Research Topics are multidisciplinary, they are cross-listed in several fields and section journals – increasing your reach even more and giving you the chance to expand your network and collaborate with researchers in different fields, all focusing on expanding knowledge around the same important topic.

    Our larger Research Topics are also converted into ebooks and receive social media promotion from our digital marketing team.

  • Frontiers offers multiple article types, but it will depend on the field and section journals in which the Research Topic will be featured. The available article types for a Research Topic will appear in the drop-down menu during the submission process.

    Check available article types here 

  • Yes, we would love to hear your ideas for a topic. Most of our Research Topics are community-led and suggested by researchers in the field. Our in-house editorial team will contact you to talk about your idea and whether you’d like to edit the topic. If you’re an early-stage researcher, we will offer you the opportunity to coordinate your topic, with the support of a senior researcher as the topic editor. 

    Suggest your topic here 

  • A team of guest editors (called topic editors) lead their Research Topic. This editorial team oversees the entire process, from the initial topic proposal to calls for participation, the peer review, and final publications.

    The team may also include topic coordinators, who help the topic editors send calls for participation, liaise with topic editors on abstracts, and support contributing authors. In some cases, they can also be assigned as reviewers.

  • As a topic editor (TE), you will take the lead on all editorial decisions for the Research Topic, starting with defining its scope. This allows you to curate research around a topic that interests you, bring together different perspectives from leading researchers across different fields and shape the future of your field. 

    You will choose your team of co-editors, curate a list of potential authors, send calls for participation and oversee the peer review process, accepting or recommending rejection for each manuscript submitted.

  • As a topic editor, you're supported at every stage by our in-house team. You will be assigned a single point of contact to help you on both editorial and technical matters. Your topic is managed through our user-friendly online platform, and the peer review process is supported by our industry-first AI review assistant (AIRA).

  • If you’re an early-stage researcher, we will offer you the opportunity to coordinate your topic, with the support of a senior researcher as the topic editor. This provides you with valuable editorial experience, improving your ability to critically evaluate research articles and enhancing your understanding of the quality standards and requirements for scientific publishing, as well as the opportunity to discover new research in your field, and expand your professional network.

  • Yes, certificates can be issued on request. We are happy to provide a certificate for your contribution to editing a successful Research Topic.

  • Research Topics thrive on collaboration and their multi-disciplinary approach around emerging, cutting-edge themes, attract leading researchers from all over the world.

  • As a topic editor, you can set the timeline for your Research Topic, and we will work with you at your pace. Typically, Research Topics are online and open for submissions within a few weeks and remain open for participation for 6 – 12 months. Individual articles within a Research Topic are published as soon as they are ready.

    Find out more about our Research Topics

  • Our fee support program ensures that all articles that pass peer review, including those published in Research Topics, can benefit from open access – regardless of the author's field or funding situation.

    Authors and institutions with insufficient funding can apply for a discount on their publishing fees. A fee support application form is available on our website.

  • In line with our mission to promote healthy lives on a healthy planet, we do not provide printed materials. All our articles and ebooks are available under a CC-BY license, so you can share and print copies.